These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16235066)

  • 1. Factors affecting a climber's ability to ascend Mont Blanc.
    Tsianos G; Woolrich-Burt L; Aitchison T; Peacock A; Watt M; Montgomery H; Watt I; Grant S
    Eur J Appl Physiol; 2006 Jan; 96(1):32-6. PubMed ID: 16235066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oximetry fails to predict acute mountain sickness or summit success during a rapid ascent to 5640 meters.
    Wagner DR; Knott JR; Fry JP
    Wilderness Environ Med; 2012 Jun; 23(2):114-21. PubMed ID: 22656656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in oxygen saturation does not predict acute mountain sickness on Jade Mountain.
    Chen HC; Lin WL; Wu JY; Wang SH; Chiu TF; Weng YM; Hsu TY; Wu MH
    Wilderness Environ Med; 2012 Jun; 23(2):122-7. PubMed ID: 22656657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing individual risk of acute mountain sickness at greater altitudes.
    Tannheimer M; Albertini N; Ulmer HV; Thomas A; Engelhardt M; Schmidt R
    Mil Med; 2009 Apr; 174(4):363-9. PubMed ID: 19485105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mt. Whitney: determinants of summit success and acute mountain sickness.
    Wagner DR; D'Zatko K; Tatsugawa K; Murray K; Parker D; Streeper T; Willard K
    Med Sci Sports Exerc; 2008 Oct; 40(10):1820-7. PubMed ID: 18799993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of acute mountain sickness in UK Military Personnel on Mount Kenya.
    Hazlerigg A; Woods DR; Mellor AJ
    J R Army Med Corps; 2016 Dec; 162(6):465-469. PubMed ID: 26604255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of residence at moderate versus low altitude on reducing acute mountain sickness in men following rapid ascent to 4300 m.
    Staab JE; Beidleman BA; Muza SR; Fulco CS; Rock PB; Cymerman A
    High Alt Med Biol; 2013 Mar; 14(1):13-8. PubMed ID: 23537255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Determinants of Acute Mountain Sickness and Summit Success on a 6-Day Ascent of Mount Kilimanjaro (5895 m).
    Lawrence JS; Reid SA
    Wilderness Environ Med; 2016 Mar; 27(1):78-84. PubMed ID: 26948557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m.
    Bloch KE; Turk AJ; Maggiorini M; Hess T; Merz T; Bosch MM; Barthelmes D; Hefti U; Pichler J; Senn O; Schoch OD
    High Alt Med Biol; 2009; 10(1):25-32. PubMed ID: 19326598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance at altitude and angiotensin I-converting enzyme genotype.
    Tsianos G; Eleftheriou KI; Hawe E; Woolrich L; Watt M; Watt I; Peacock A; Montgomery H; Grant S
    Eur J Appl Physiol; 2005 Mar; 93(5-6):630-3. PubMed ID: 15578201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent.
    Gertsch JH; Seto TB; Mor J; Onopa J
    High Alt Med Biol; 2002; 3(1):29-37. PubMed ID: 12006162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressurization and acute mountain sickness.
    Kayser B; Jean D; Herry JP; Bärtsch P
    Aviat Space Environ Med; 1993 Oct; 64(10):928-31. PubMed ID: 8240197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of ascent and acute mountain sickness at high altitude.
    Hsu TY; Weng YM; Chiu YH; Li WC; Chen PY; Wang SH; Huang KF; Kao WF; Chiu TF; Chen JC
    Clin J Sport Med; 2015 Mar; 25(2):95-104. PubMed ID: 24751723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in spirometric parameters and arterial oxygen saturation during a mountain ascent to over 3000 meters].
    Compte-Torrero L; Botella de Maglia J; de Diego-Damiá A; Gómez-Pérez L; Ramírez-Galleymore P; Perpiñá-Tordera M
    Arch Bronconeumol; 2005 Oct; 41(10):547-52. PubMed ID: 16266667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m).
    Davies AJ; Kalson NS; Stokes S; Earl MD; Whitehead AG; Frost H; Tyrell-Marsh I; Naylor J
    Wilderness Environ Med; 2009; 20(4):311-7. PubMed ID: 20030437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variables contributing to acute mountain sickness on the summit of Mt Whitney.
    Wagner DR; Fargo JD; Parker D; Tatsugawa K; Young TA
    Wilderness Environ Med; 2006; 17(4):221-8. PubMed ID: 17219785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exercise and the detection of severe acute mountain sickness].
    Garófoli A; Montoya P; Elías C; Benzo R
    Medicina (B Aires); 2010; 70(1):3-7. PubMed ID: 20228017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya.
    Vardy J; Vardy J; Judge K
    Aviat Space Environ Med; 2006 Jul; 77(7):742-4. PubMed ID: 16856361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
    Grissom CK; Richer LD; Elstad MR
    Chest; 2005 Feb; 127(2):565-70. PubMed ID: 15705997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral arterial desaturation is further exacerbated by exercise in adolescents with acute mountain sickness.
    Major SA; Hogan RJ; Yeates E; Imray CH
    Wilderness Environ Med; 2012 Mar; 23(1):15-23. PubMed ID: 22441084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.